10-Q: Community Healthcare Trust Reports Q3 Loss, Higher Expenses

Community Healthcare Trust Incorporated reported a wider net loss and decreased FFO and AFFO for the nine months ended September 30, 2025, impacted by one-time expenses and credit loss reserves.

Summary

• Net loss for the nine months ended September 30, 2025, widened to $9.3 million, compared to a net loss of $5.0 million for the same period in 2024.
• Basic and diluted net loss per common share for the nine months ended September 30, 2025, was $0.43, compared to $0.27 for the same period in 2024.
• Rental income increased by 5.9% to $90.7 million for the nine months ended September 30, 2025, from $85.6 million in 2024, primarily due to acquisitions.
• General and administrative expenses surged by 42.6% to $20.3 million for the nine months ended September 30, 2025, largely due to $4.6 million in accelerated stock-based compensation and $1.3 million in severance expenses related to a management termination.
• Interest expense increased by 15.7% to $20.0 million for the nine months ended September 30, 2025, driven by higher weighted average debt balances and interest rates.
• A credit loss reserve of $8.7 million was recorded for notes receivable with a geriatric inpatient behavioral hospital tenant, fully reserving these notes in 2025, following an $11.0 million reserve in 2024.
• Funds from Operations (FFO) decreased to $32.6 million ($1.20 per diluted share) for the nine months ended September 30, 2025, from $38.5 million ($1.44 per diluted share) in 2024.
• Adjusted Funds from Operations (AFFO) decreased to $43.4 million ($1.60 per diluted share) for the nine months ended September 30, 2025, from $44.6 million ($1.67 per diluted share) in 2024.
• Net Operating Income (NOI) increased by 5.1% to $72.6 million for the nine months ended September 30, 2025, from $69.1 million in 2024.
• The company acquired two real estate properties for approximately $36.0 million during the first nine months of 2025, adding 75,000 square feet to its portfolio.
• The real estate portfolio was approximately 90.1% leased as of September 30, 2025, excluding assets held for sale.
• The company declared a quarterly common stock dividend of $0.4750 per share on October 23, 2025, equating to an annualized dividend of $1.90 per share.

Sentiment

Score: 4

Explanation: The financial results for the nine months ended September 30, 2025, show a significant increase in net loss and a decrease in key profitability metrics (FFO, AFFO) compared to the prior year. While rental income and NOI grew, these were overshadowed by substantial increases in general and administrative expenses (due to one-time events) and interest expense, along with significant credit loss reserves. The strong acquisition pipeline and capital recycling program offer future potential, but current performance is weak.

Positives

• Rental income increased by 5.9% to $90.7 million for the nine months ended September 30, 2025, driven by property acquisitions.
• Net Operating Income (NOI) increased by 5.1% to $72.6 million for the nine months ended September 30, 2025, indicating improved operational performance at the property level.
• Adjusted EBITDAre increased to $64.6 million for the nine months ended September 30, 2025, from $62.8 million in 2024.
• The company maintains a strong acquisition pipeline with six properties under definitive purchase agreements for an aggregate expected purchase price of $146.0 million.
• A capital recycling program is underway, with an expected sale of an inpatient rehabilitation facility in Q4 2025 projected to yield an $11.5 million gain.
• The company successfully acquired two new properties for $36.0 million, expanding its portfolio by 75,000 square feet, with both properties 100% leased.
• The company was in compliance with its financial covenants under its Credit Facility as of September 30, 2025.
• The quarterly common stock dividend was maintained at $0.4750 per share, demonstrating commitment to shareholder returns despite current period losses.

Negatives

• Net loss significantly widened to $9.3 million for the nine months ended September 30, 2025, compared to $5.0 million in the prior year.
• Basic and diluted net loss per common share worsened to $0.43 for the nine months ended September 30, 2025, from $0.27 in 2024.
• Funds from Operations (FFO) decreased by 15.4% to $32.6 million, and FFO per diluted share decreased by 16.7% to $1.20.
• Adjusted Funds from Operations (AFFO) decreased by 2.7% to $43.4 million, and AFFO per diluted share decreased by 4.2% to $1.60.
• General and administrative expenses increased substantially by 42.6% due to $4.6 million in accelerated stock-based compensation and $1.3 million in severance expenses from a management termination.
• An additional credit loss reserve of $8.7 million was recorded for notes receivable with a geriatric inpatient behavioral hospital tenant, indicating ongoing issues with this specific tenant.
• Interest expense increased by 15.7% to $20.0 million, impacting profitability.
• Cash and cash equivalents decreased to $3.38 million at September 30, 2025, from $4.38 million at December 31, 2024.
• Total debt, net, increased to $530.1 million at September 30, 2025, from $486.0 million at December 31, 2024.

Risks

• General volatility of the capital markets and the market price of the common stock.
• Changes in business strategy, availability, terms, and deployment of capital.
• Ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all.
• Changes in the real estate industry in general, interest rates, or the general economy.
• Adverse developments related to the healthcare industry.
• Changes in governmental regulations.
• The degree and nature of competition.
• Ability to consummate acquisitions under contract, as assurance cannot be provided on timing or closing.
• Catastrophic or extreme weather and other natural events and the physical effects of climate change.
• The occurrence of cyber incidents.
• Effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or conflicts in Ukraine and the Middle East.
• Changes to U.S. tariff and import/export regulations may have an adverse effect on business, financial condition, and results of operations.

Future Outlook

The company anticipates closing on one property from its acquisition pipeline in the fourth quarter of 2025, with the remaining five properties expected to close throughout 2026 and 2027. These acquisitions are expected to be funded through cash from operations, equity or debt issuances, the Revolving Credit Facility, or asset sales. As part of its capital recycling program, the company expects to sell an inpatient rehabilitation facility in Q4 2025, recognizing an estimated gain of $11.5 million, with proceeds generally intended to fund acquisitions through like-kind exchanges.

Management Comments

• Management monitors factors and trends important to the company and the REIT industry to gauge their potential impact on operations.
• The company expects to meet its liquidity needs through cash on hand, cash flows from operations, and cash flows from equity or debt issuances, its Credit Facility, or asset sales.
• The company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements, but cannot be certain that these funds will be available at a time and upon terms acceptable to the company in sufficient amounts.

Industry Context

The healthcare real estate sector, in which Community Healthcare Trust operates, is influenced by demographic trends such as an aging population, increasing demand for healthcare services, and the ongoing need for specialized medical facilities. However, the industry also faces challenges from rising interest rates, which increase borrowing costs for REITs, and inflationary pressures impacting operating expenses and capital expenditures. The company's increased interest expense and credit loss reserves reflect broader economic headwinds and specific tenant challenges, while its continued acquisitions and development pipeline indicate a long-term growth strategy within the sector.

Comparison to Industry Standards

• The filing does not provide specific comparisons to comparable companies, projects, or global benchmarks within the healthcare REIT industry. However, the company's FFO and AFFO per share declines, coupled with increased net loss, suggest underperformance relative to a stable or growing industry benchmark, especially considering the general resilience often seen in healthcare REITs due to the essential nature of their tenants' services. Without specific peer data in the filing, a direct quantitative comparison is not possible.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not aware of any pending or threatened litigation that, if resolved against the company, would have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Related Party Transactions

• No specific related party transactions were explicitly disclosed beyond standard executive compensation plans (restricted stock and RSU agreements) and the general statement that the company's material subsidiaries are guarantors of the obligations under the Credit Facility.

Stakeholder Impact

• **Shareholders**: Negative impact from increased net loss, decreased FFO/AFFO per share, and increased debt. Positive impact from maintained dividend and potential future growth from acquisitions and capital recycling.
• **Employees**: Impacted by the termination of a key executive, leading to severance and accelerated compensation. Ongoing incentive programs (restricted stock, RSUs) are in place.
• **Tenants**: One geriatric inpatient behavioral hospital tenant is experiencing significant financial distress, leading to substantial credit loss reserves for the company. Other tenants are contributing to rental income growth.
• **Creditors**: Increased debt levels, but the company remains in compliance with Credit Facility covenants. Interest rate swaps mitigate some floating rate risk.

Next Steps

• Close on one property from the acquisition pipeline in the fourth quarter of 2025.
• Close on the remaining five properties in the acquisition pipeline throughout 2026 and 2027.
• Complete the sale of an inpatient rehabilitation facility in Q4 2025 as part of the capital recycling program.
• Fund future acquisitions and capital expenditures through cash from operations, equity/debt issuances, the Revolving Credit Facility, or asset sales.
• Continue to manage liquidity and capital resources, including compliance with Credit Facility covenants.

Key Dates

Recommendation

The filing presents a mixed financial picture. While the company achieved growth in rental income and NOI, indicating healthy underlying property performance, the bottom-line metrics (net loss, FFO, AFFO) significantly deteriorated. This was largely driven by one-time severance costs, accelerated stock compensation, and substantial credit loss reserves related to a distressed tenant. These factors suggest operational challenges and specific tenant risks that are impacting current profitability. However, the company maintains a robust acquisition pipeline and a capital recycling program with an expected significant gain, which could drive future growth and improve financial performance. The dividend has been maintained, which is a positive for income-focused investors. Given the current headwinds impacting profitability versus the long-term growth strategy and dividend stability, a 'hold' recommendation is appropriate. Investors should monitor the resolution of the distressed tenant situation, the execution of the acquisition pipeline, and the impact of interest rate trends.

Keywords

Healthcare REIT, Real Estate Investment Trust, Medical Office Building, Inpatient Rehabilitation Hospitals, Behavioral Specialty Facilities, Healthcare Properties, SEC Filing, 10-Q, Financial Results, Acquisitions, Dispositions, Credit Facility, Dividends, FFO, AFFO, Net Operating Income, EBITDAre, Restricted Stock Units, Capital Recycling